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ABSTRACT
tRNAs are synthesized as precursor RNAs that have
to undergo processing steps to become functional.
Yeast Trz1 is a key endoribonuclease involved in the
3′ maturation of tRNAs in all domains of life. It is a
member of the -lactamase family of RNases, char-
acterized by an HxHxDH sequence motif involved in
coordination of catalytic Zn-ions. The RNase Z fam-
ily consists of two subfamilies: the short (250–400
residues) and the long forms (about double in size).
Short form RNase Z enzymes act as homodimers:
one subunit embraces tRNA with a protruding arm,
while the other provides the catalytic site. The long
form is thought to contain two fused −lactamase
domains within a single polypeptide. Only structures
of short form RNase Z enzymes are known. Here we
present the 3.1 Å crystal structure of the long-form
Trz1 from Saccharomyces cerevisiae. Trz1 is orga-
nized into two -lactamase domains connected by a
long linker. The N-terminal domain has lost its cat-
alytic residues, but retains the long flexible arm that
is important for tRNA binding, while it is the other way
around in the C-terminal domain. Trz1 likely evolved
from a duplication and fusion of the gene encoding
the monomeric short form RNase Z.
INTRODUCTION
Transfer RNAs (tRNAs) play the key role in mRNA de-
coding during translation by the ribosome. They are usu-
ally synthesized as long precursors and subsequently pro-
cessed by removing the 5′ and 3′ extensions (1). Maturation
of tRNA further requires the addition of a CCA-motif to
the 3′ terminus (in cases where it is not encoded) and chem-
ical modifications of nucleotides in various positions. The
5′ end is trimmed by either the RNase P ribozyme or a pro-
tein only variant (1,2), while the 3′ processing can involve
either endo- or exonucleolytic cleavages (3–5). In eukary-
otic cells, tRNAs are mainly processed endonucleolytically
and the exonucleolytic pathway is minor. The order of 5′
and 3′ processing events is variable and is likely to be tRNA
specific.
RNase Z is the enzyme responsible for the 3′ endonu-
cleolytic cleavage of tRNA precursors in all three domains
of life, as shown in Methanococcus janaschii (6), Bacil-
lus subtilis (7), Drosophila melanogaster (8), Arabidopsis
thaliana (9), human mitochondria (10) and Schizosaccha-
romyces pombe (11). RNase Z enzymes belong to the family
of Zn-dependent -lactamases with a highly-conserved Zn-
coordinating signature motif HxHxDH (in which x repre-
sents any hydrophobic amino acid). They are further clas-
sified according to their sequence length into two groups:
the short form RNase ZS (also termed ELAC1 in hu-
mans, between 250 and 400 residues) present in bacteria,
archaea and eukaryotes and the long form RNase ZL (also
termed ELAC2 in humans, between 750 and 900 residues)
found exclusively in eukaryotes (12,13). Some eukaryotes
(D. melanogaster, Caenorhabditis elegans, Saccharomyces
cerevisiae and S. pombe) only have the RNase ZL form
while others (Homo sapiens, Mus musculus, Danio rerio, A.
thaliana) have both the RNase ZS and RNase ZL forms,
usually with differential sub-cellular localizations. Muta-
tions in the human RNase ZL have been associated with
an increased risk of prostate cancer (14,15) and cardiomy-
opathies in humans (16), showing the importance of this en-
zyme in general cell well-being.
The crystal structures of RNase ZS enzymes from B. sub-
tilis, Thermotoga maritima, Escherichia coli and H. sapiens
are known (17–20). They all adopt the -lactamase fold
and their HxHxDH motifs are involved in coordinating
the enzymatically essential Zn ions. A flexible arm (also
called the exosite) is inserted between the third and fourth
-strands of the -helix flanked central -core. This arm
is composed of a compact globular domain extruded from
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the −lactamase core by an extended two-stranded stalk.
All the documented RNase ZS structures form similar ho-
modimers with the two subunits in a head to head arrange-
ment. The structure of B. subtilis RNase Z (BsuTrz) bound
to tRNA was very informative on how the two subunits of
the dimer play different functional roles (18). The tRNA
substrate is wedged between the flexible arm of one subunit
and the 7 helix of the other. The 7 helix thus helps guide
the 3′ end of the tRNA toward the active site of the subunit
opposite that containing the clamping flexible arm.
Saccharomyces cerevisiae has been shown to have tRNA
3′ endonucleolytic activity localized both in the nucleus and
in the mitochondria, coded by the TRZ1 gene (17,21,22).
The Trz1 protein is of the long form RNase ZL type and
is composed of two domains connected by a long linker
(about 60 residues). The C-terminal domain (CTD) shares
significant sequence identity with the RNase ZS enzymes
while the sequence of the N-terminal domain (NTD) di-
verges from that of the -lactamase family. Despite this se-
quence divergence it was predicted that the NTD would also
have a −lactamase fold (23). While the N-terminal half of
Trz1 has lost the HxHxDH, the PxKxRN (P-loop) and the
AxDx motifs important for the cleavage reaction, it was pre-
dicted to contain the flexible arm, involved in tRNA bind-
ing. On the other hand, the CTD contains a full set of cat-
alytic residues, but has lost the flexible arm insertion. In this
manuscript we present the crystal structure of the full length
Trz1 at a resolution of 3.1Å. Our data confirm the presence
of two similar -lactamase domains, but only the CTD con-
tains a fully structured catalytic center. The structure sug-
gests an evolutionary scenario whereby Trz1 evolved from
a gene fusion event between two copies encoding the short
form RNase Z.
MATERIALS AND METHODS
Protein expression and purification
The ORF encoding Trz1 was cloned into the pET-45 vector
(Novagen) with the N-terminus in fusion with a 6xHis-tag
and a linker containing an enterokinase cleavage site (un-
derlined) (the linker coded for the following peptide MA
HHHHHHVG TGSNDDDDKS PDPNWELVYT ARLQ
EF). Trz1 was expressed at 15◦C o/n using the transformed
E. coli BL21 Gold (DE3) strain and 2YT medium, sup-
plemented with 100 g/ml ampicillin. Cells were harvested
by centrifugation, suspended in 20 mM Tris–HCl, pH 7.5,
500 mM NaCl, 5 mM -mercaptoethanol plus 10% glycerol
and stored at −20◦C. Cells were lysed by sonication, puri-
fied by Ni-NTA agarose column (Qiagen), followed by an
ion-exchange column (Mono Q 5/50 GL, GE healthcare)
in a buffer containing 20 mM Tris–HCl, pH 7.5, 10 mM
-mercaptoethanol and 10% glycerol, using a gradient be-
tween 50 mM (low salt) and 500 mM (high salt) NaCl. The
final gel filtration (column Superdex 200 Hiload 16/60, GE
healthcare) was carried out in a buffer containing 20 mM
Tris–HCl, pH 7.5, 10 mM -mercaptoethanol, 10% glycerol
and 100 mM NaCl. The Se-Methionine labeled version of
Trz1 was prepared using standard protocols and purified in
the same way as the native protein (24).
Structure determination of Trz1
Crystallization screening (Qiagen PEGs kit) of Trz1 was
performed at 18◦C by the sitting drop vapor diffusion
method, using a CARTESIAN pipetting robot. Crystals
of seleno-methionine labeled Trz1 were obtained in 0.1 M
Hepes, pH 7.5, 25% (w/v) PEG 8K, using a protein con-
centration of 5 mg/ml supplemented with 1 mM dGMP.
The protein was mixed with reservoir solution at a 1:1 ra-
tio. Crystals of approximate dimension 60 × 120 × 60
m appeared within three days. Crystals were cryo-cooled
using mother liquor supplemented with 20% glycerol as
cryo-protectant. SAD data were collected on the Prox-
ima1 beamline at the SOLEIL synchrotron radiation facil-
ity (Saint-Aubin, France) using a Pilatus detector. The data
were processed by the XDS package (25). The crystals had
the space group P41 and contained two copies of Trz1 per
asymmetric unit (Table 1). The positions of the Se atoms
were located using the SHELX C/D/E programs (26). The
program Profess from the CCP4 suite (K. Cowtan) was suc-
cessful in finding the non-crystallographic symmetry opera-
tor. The positions of 22 Se-sites were refined and the phasing
was performed by the program Phaser SAD pipeline from
CCP4 suite (27). After several cycles, 36 sites were finally
identified and the resolution extended to 3.39 Å. The phases
were further improved by map density modification using
the program Parrot (K. Cowtan, CCP4 suite). Both copies
in the asymmetric unit were used to complete the model. We
used the program Buccaneer for automatic model building
(28) and refined the model with the program Refmac5 to
3.1 Å resolution (29). The coordinates were deposited at the
Protein Data Bank (PDB code: 5MTZ).
RESULTS
Trz1 is composed of two -lactamase domains connected by
a long linker
No crystal structure was previously available for a RNase
ZL. To probe the mechanistic differences between short and
long form RNase Z enzymes we set out to obtain structural
information on Trz1, the long form RNase Z from yeast.
Recombinant Trz1 supplemented with a polyhistidine-tag
was expressed in E. coli and purified according to standard
protocols. Small crystals in the spacegroup P41 were ob-
tained in 0.1 M HEPES buffer pH 7.5 and 25% PEG8K.
The structure was solved at 3.1 Å resolution using a com-
plete SAD data set collected on Se-methionine substituted
crystals (Table 1), which diffracted better than the native
protein crystals (data not shown) and which were therefore
used for the refinement. The refinement yielded an R-factor
of 18.6% (Rfree 25.4%) and a model with good stereochem-
istry. The crystals had two copies of Trz1 in the asymmet-
ric unit with an r.m.s.d. of 0.71 Å (Supplementary Figure
S1A). The current model includes regions 1–204, 246–623
and 636–820 in one copy and regions 1–204, 247–623 and
637–809 in the other. A phenylalanine was also visible in
both copies at the N-terminus introduced by the fusion with
the affinity tag which was not removed from the protein
construct. There was clear residual electron density for four
Zn2+ ions and two phosphate moieties. The protein regions
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Table 1. Data collection and refinement statistics
Trz1-SeMet
X-ray source Proxima 1
Wavelength (Å) 0.9792
Temperature (K) 100
Unit-cell parameters (Å, ◦) a = 136.0, b = 136.0, c = 115.8,  =  =  = 90.0
Space group P41
Resolution limitsa (Å) 49.6–3.1 (3.3–3.1)
Number of observationsa 589 612 (91 190)
Number of unique reflectionsa 76 016 (12 111)
R-measa (%) 25.8 (180.0)
Completenessa (%) 99.7 (98.5)
I/a (I) 8.13 (1.13)
CC(1/2) (%) 99.1 (52.0)
Anomal Corra,b 38 (19)
SignAnoa,b,c 1.14 (0.96)
Number of non-hydrogen atoms (Protein/other) 12 426/14
R/Rfree (%) 18.58/25.43
R.M.S.D. Bonds (Å)/angles (◦) 0.01/1.61
Average temperature factors (Å2) (Protein/other) 83.29/85.53
aValues in parentheses refer to the highest resolution shell.
bValues for resolution limits: 49.61–3.5 (3.78–3.5).
cMean anomalous difference in units of its estimated standard deviation (|F(+)−F(−)|/Sigma). F(+), F(−) are structure factor estimates obtained from
the merged intensity observations in each parity class.
with missing electronic density are likely explained by their
mobility in the crystal.
Trz1 is composed of two main domains connected by an
extensive linker (Figure 1A). The NTD is contained be-
tween residues 1 and 404 and the CTD between residues
466 and 818. As predicted by sequence analysis, the CTD
belongs to the -lactamase family of Zn-dependent hydro-
lases. Its structure is very like that of the BsuTrz (PDB code:
2FK6, Z-factor 28.8, r.m.s.d. = 2.3 Å for 251 aligned C po-
sitions and 24% sequence identity) (Figure 1B) and the hu-
man ELAC1 (PDB code: 3ZWF, Z-factor 26.4, r.m.s.d. =
2.3 Å for 237 aligned C positions and 24% sequence iden-
tity). Despite weak sequence identity with the RNase Z fam-
ily members, the NTD of Trz1 also possesses a -lactamase
fold (Figure 1C). The NTD consists of two opposing seven-
strand -sheets sandwiched by -helices. The first four -
strands (7, 8, 9, 10 and 14, 1, 2, 3) are antipar-
allel and the next three are parallel in each of the sheets. The
CTD also consists of two opposing -sheets sandwiched by
-helices, but only one of the -sheets has seven strands
(28, 16, 17, 18 antiparallel; 19, 20, 21 parallel);
the other is six-stranded (22, 23, 24, antiparallel; 25,
26, 27 parallel) and lacks the first -strand compared to
BsuTrz. The linker between the two domains forms an elon-
gated peptide stretch (residues 405–423) that extends the -
sheet of the NTD, followed by two short -helices and a
second irregular stretch that interacts with the CTD (Fig-
ure 1A).
The two domains of Trz1 both possess long extensions
from the core, which are not present in RNase ZS sequences,
here named Ext-I, Ext-II, Ext-III and Tail (Figure 1B and
C). Ext-I of the NTD is situated between strands 8 and 9
(residues 136–191); it contains a helix (4) and an irregu-
lar peptide stretch that mainly interact with the N-terminal
core. Ext-II from the NTD is a long connection between
strands 12 and 13 (residues 319–356) that contains a he-
lix (7, residues 330–342) inserted between the core of the
CTD and the helical part of the linker peptide (Figure 1C).
This linker therefore contributes considerably to the inter-
action surface between the two domains. Ext-III is in the
CTD, between the -strands 21 and 22 (residues 600–
659). The tail of the CTD (residues 792–818) also has a long
helix (19, residues 795–809) that together with the linker
helices and helix 7 (from the NTD), forms a helical bundle
sub-domain (Figure 1B).
N- and C-terminal domain comparison
The two domains of Trz1 superimpose well (r.m.s.d. = 3.3
Å for 228 aligned C positions and 13% sequence identity,
Z-factor = 15.1; Figure 1D) but they also have a few sig-
nificant structural differences. First, the key catalytic Zn-
binding residues are only present in the CTD and are re-
placed in the NTD by ‘pseudo -motifs’ (Figure 2A and
B). Residual electron density at the active site situated in
the CTD of Trz1 revealed the presence of two Zn ions
separated by 3.6 Å that are bridged by a phosphate ion
bound by His737 (Figure 3D). The two Zn ions are fur-
ther coordinated by five histidines (His540, His542, His545,
His670 and His759) and two aspartate residues (Asp544
and Asp699). The coordination sphere of the two Zn ions
in the Trz1 CTD is perfectly superimposable on that of the
Zn ions in the RNase ZS structures (Figure 3C). Thus, the
Trz1 CTD is clearly the catalytically active domain while
the Trz1 NTD has lost its catalytic residues during evolu-
tion. It is interesting to compare this to the situation in the
BsuTrz holo-enzyme crystal structure where the active site
of the A subunit contained two coordinated Zn ions while
the active site in the B subunit lacked bound metal ions
and was in an inactive conformation (15). The backbones
of the  -motif II residues are superimposable in the two do-
mains, but the central HxHxDH signature of motif II is lost
in the NTD (Figure 2A and B). The same holds for motif
I (Asp): the backbone is superimposable for both domains
but Asp508 which helps to stabilize His545 in motif II is lost
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Figure 1. Structure of Trz1. (A) Cartoon presentation of the Trz1 structure. The N-terminal domain (NTD) and C-terminal domain (CTD) are shown in
green and cyan, respectively, and the linker is shown in purple. Two zinc ions are shown as yellow spheres and the phosphate ion is shown as sticks (present
in the active site). The region corresponding to the unresolved flexible arm protruding from the NTD is shown as a dashed line and the loop replacing the
flexible arm in the CTD is in red (labeled with an asterisk). (B) The CTD of Trz1 superimposed on BsuTrz (transparent gray, PDB code: 1y44). The core
of the CTD is shown in cyan and the extensions are in orange. The conserved tRNA recognition elements 17 and loop PxKxRN and the nearby AxDx
loop in the CTD are in blue. The NTD of Trz1 is shown as a green ribbon and the linker region is shown in purple. (C) The NTD of Trz1 superimposed on
BsuTrz (transparent gray). The -lactamase core of the NTD is shown in green and the extensions are in yellow. The CTD of Trz1 is shown as blue ribbon.
(D) Superimposition of the NTD (green) and CTD (cyan) of Trz1 (linker in purple).
in the NTD. Motifs III (His), IV (Asp) and V (His) are ab-
sent in the NTD and the presence of the Ext-I and Ext-II ex-
tensions completely changes the conformation of the corre-
sponding regions. The HEAT (Glu721) -17- HST (His737)
motif, which is essential for both binding and cleavage of the
tRNA precursor, is present in the CTD but is replaced in the
NTD by a short loop (residues 278–295). Also the PxKxRN
and AxDx motifs, involved in pre-tRNA binding and cleav-
age, are only present in the CTD (Figure 2A). The AxDx
motif is conserved in the eukaryotic RNase ZL and bacte-
rial RNase ZS sequences. This loop is involved in the cleav-
age reaction and has the potential to form hydrogen bonds
with the PxKxRN loop. It was shown that an aspartate to
alanine mutation in the AxDx motif affected cell viability
of S. pombe (30,31).
Another important functional difference between the
NTD and CTD in the regions implicated in the binding of
tRNA. In the crystal structure of the RNase ZS/tRNAThr
complex (7,18), tRNA is wedged between the flexible arm
of one subunit and the 7 helix of the other. In Trz1, the
flexible arm between residues 203 and 251 is disordered in
the NTD and replaced by a short loop in the CTD (Fig-
ure 1A) suggesting this half of Trz1 does not interact with a
tRNA substrate (see ‘Discussion’ section). Superimposing
the Trz1 NTD onto RNase ZS structures showed that the
flexible arm emanates from the same position on the surface
in both forms of RNase Z, i.e. between the third and fourth
-strand of the core domain (Figure 1C). A second region
involved in tRNA binding provided by the alpha-helix be-
tween the HEAT and the HST motifs (7 in the BsuTrzS
crystal structure) is present in the CTD (17, Figure 3A)
but replaced by a short loop in the NTD. Thus the two do-
mains of Trz1 clearly have distinct biochemical roles.
Trz1 mimics the RNase ZS dimer
Trz1 superimposes well onto the BsuTrz dimer (Supplemen-
tary Figure S2A). The NTD and CTD interact tightly and
are in the same position as the two subunits of the RNase
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Figure 2. Active site motifs. (A) Stereo views of the -histidine motif in NTD (upper panels) and Zn-binding His-motif in CTD (lower panels). (B)
Structure based sequence alignment of the conserved motifs in C- and NTDs: PxKxRN loop, motif I to V and AxDx motif. RNase ZL sequences from
Saccharomyces cerevisiae (Sce = Trz1), Caenorhabditis elegans (Cel), Drosophila melanogaster (Dme), Mus musculus (Mmu) and Homo sapiens (Hsa)
are represented.
ZS dimers. The major interface between the two domains
is contributed by three major −helices, namely 1/11,
2/13 and 3/14 from the NTD and CTD, respectively.
Interaction between the domains is reinforced by the linker
region and by the extensions emanating from the NTD
(Supplementary Figure S2B and C). BsuTrz alone showed
an asymmetry in the two subunits of the dimer: in one sub-
unit, the protruding arm was disordered and in the other it
was stabilized through crystal contacts (17). In the complex
of BsuTrz with substrate tRNAThr this flexible arm reaches
out from the core of the protein to embrace the T-arm of
the tRNA substrate, while the acceptor end of the tRNA
plunges into the active site of the other subunit (18). One
of the subunits of the BsuTrz dimer is responsible for the
main contacts with the tRNA substrate while the other sub-
unit provides the catalytic site competent for tRNA cleav-
age. This structure shows that the dimeric short form RNase
Z can process two tRNAs simultaneously.
In contrast, Trz1 consists of two domains that mimic the
structure of the dimeric RNase ZS. The NTD lacks the Zn-
binding residues but has a protruding arm that is likely in-
volved in clamping of the tRNA substrate. The CTD has a
properly formed active site responsible for the cleavage reac-
tion. The tRNA substrates are likely bound and processed
in a very similar way by the long and short RNase Z forms,
except that RNase ZL can process only one tRNA at a time.
Our structural data confirm that RNase ZL likely originated
through gene duplication and divergent evolution of the two
original subunits, resulting in the loss of the flexible arm and
catalytic site from the NTD and CTD, respectively
DISCUSSION
Eukaryotes encode at least one long form RNase Z (yeast,
H. sapiens), but many organisms have both the long and
short form of this tRNA 3′ processing enzyme (e.g. H. sapi-
ens, A. thaliana). The short RNase Z proteins are active
as homodimers, whereas the long forms act as monomers.
Our crystal structure of Trz1 strengthens the hypothesis that
RNase ZL arose from a gene duplication-fusion event from
an RNaseZS. Despite a considerable sequence divergence
between the N- and C-terminal halves of Trz1, both pos-
sess a very similar −lactamase structure. The crystal struc-
ture of Trz1 clearly explains why RNase ZL is monomeric
while the short form is dimeric. The two -lactamase do-
mains of Trz1 can be superimposed on the two subunits
of the short form RNase Z and clearly mimic the struc-
ture of the dimer (Figure 1B and C). The interactions be-
tween the NTD and CTD of Trz1 are reinforced by nu-
merous contacts provided by the long extensions emanat-
ing from the N-terminal half and by the linker. To analyze
the functional organization of the RNase ZL forms, we cre-
ated a model of a Trz1/tRNA complex by superimposing
the structure of Trz1 onto that of the BsuTrz/tRNAThr com-
plex (PDB code: 2FK6; Figure 3A). The two Trz1 domains
superimpose very well with the BsuTrz dimer and tRNAThr
fits perfectly onto the Trz1 surface. A minor steric clash is
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Figure 3. Model of Trz1 in complex with tRNA. (A) This model was generated by superimposition of Trz1 onto the BsuTrz/tRNA complex (PDB code:
2FK6). The N- and C-terminal halves and linker of Trz1 are shown in green/cyan and purple, respectively. For clarity, BsuTrz was omitted in the figure and
only the tRNA (orange) is shown. Arrows indicate the position of the flexible arm and acceptor stem. The active center residues of Trz1 are shown as pink
sticks, and zinc ions as yellow spheres. The 17 helix and the ‘PxKxRN’ and AxDx loops are shown in blue. (B) Sequence conservation projected onto the
surface of Trz1 as generated with default parameters by the consurf webserver (http://consurf.tau.ac.il). The complex is shown in the same orientation as
for panel A. (C) Zoom on the superimposition of the active site residues of Trz1 and BsuTrz. Only Trz1 residues are labeled and BsuTrz residues are shown
as gray sticks. (D) Zoom on the active site of the Trz1/tRNA complex. The tRNA is shown as orange sticks and the uracil 73 is labeled.
generated between tRNAThr and residues 760 and 769 of
Trz1, situated in a long loop that is probably subject to con-
formational changes upon substrate binding. Although the
structure and association of the two Trz1 domains strongly
mimic the dimer of BsuTrz, the functional roles of the two
domains are clearly separated. First, the flexible arm present
in the NTD of Trz1, although disordered in absence of sub-
strate tRNA, is well positioned to play the same role in
tRNA clamping as for BsuTrz. In the CTD, the flexible arm
is replaced by a short loop instead that is clearly too short to
embrace the T arm of the tRNA, but the 17 helix (equiva-
lent to helix 7 in BsuTrz) is present. In our model the 3′-end
of the tRNAThr substrate fits precisely into the active cen-
tre of the CTD and establishes contacts with Trz1 that are
identical to those observed for the BsuTrz/tRNAThr com-
plex (Figure 3D). In addition, the acceptor stem of tRNAThr
is bound by the 17 helix and the PxKxRN loop motif
of the CTD. The active site region of the C-terminal Trz1
domain is positively charged and highly conserved (Figure
3B), as would be expected. We conclude that our model of
the Trz1/tRNA complex obtained by simple superimpos-
ing the Trz1 and the BsuTrz/tRNAThr complex structures
highlights the functional segregation between the NTD and
CTD: the NTD primarily recognizes the tRNA substrate
and the CTD is responsible for the cleavage reaction. The
complete catalytic machinery used by BsuTrz is perfectly su-
perimposable onto that of the CTD of Trz1. The histidines
from motifs II, III and V, the aspartates from motif I, II, IV,
a phosphate ion and a water molecule provide a pseudo-
octahedral coordination of the two zinc ions, constituting
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the catalytic centre (Figure 3D). By analogy with what was
proposed for BsuTrz, the negatively charged Asp544 (Asp67
in BsuTrz) likely acts as a general base and deprotonates a
neighboring water (17,23). The nucleophilic hydroxyl group
then attacks the cleavable phosphate linkage of the tRNA
substrate that is polarized by the two zinc ions, resulting
in the breakage of the phospho-diester bond between nu-
cleotide 73 and 74. Then the 3′ position of tRNA restores
its hydroxy-group by protonation through a water molecule.
A number of mutations found in the human ELAC2
gene have been connected with various diseases. Trz1 and
ELAC2 share 21% sequence identity and 49% similarity
(the sequence alignment for some RNaseZL orthologs is
represented in Supplementary Figure S2F). With the help
of the structure of Trz1 we explored the locations of these
mutations. ELAC2 has been tagged as a prostate cancer
susceptibility gene (15). The related mutations are S217L,
A541T and R781H, three residues that are not conserved
in Trz1 (Supplementary Figure S2F). A fourth mutation is
a guanine insertion after base 1641, causing premature ter-
mination of ELAC2 translation (14). None of the mis-sense
mutations affect ELAC2 catalytic activity (14), suggesting
that their link to cancer is more likely due to another prob-
lem such as a defect in its association with other partners.
Ser217 is found in a region corresponding to Ext-I in Trz1
(residues 136–190) whose sequence is not conserved among
species; Arg781 is in the tail of ELAC2 that corresponds
to the disordered C-terminal region of Trz1. Ala541 aligns
with Met535 in Trz1, a residue of the hydrophobic core of
the CTD. The positions of these mutations in the 3D struc-
ture of Trz1 are consistent with the possibility that they af-
fect protein–protein interactions.
ELAC2 mutations were also found to be associated with
hypertrophic cardiomyopathy, which is caused by a mito-
chondrial RNA processing defect (16). The four related mu-
tations are F154L, L423F, T520I and a STOP mutation at
Arg211. Phe154 (Tyr102 in Trz1) is at the end of helix 3
at the interface between the two domains. Thr520 (Thr513
in Trz1) is in the conserved Motif I of the CTD. Introduc-
tion of the T520I mutation into TRZ1 caused a pheno-
type indicative of impaired respiratory chain function, a re-
duced growth rate on medium containing non-fermentable
carbon sources; a higher petite frequency is also observed
with this mutant, indicating quantitatively reduced mito-
chondria translation (16). Mutation of the equivalent in
DmeTrzL23 (Thr471) reduced the activity 10-fold (32). It
is interesting to note that Thr520 is part of helix 1, which
is also at the interface between the NTD and CTD. Leu423
is located in the beginning of the linker region between the
strands 14 and 15, and is not conserved in Trz1. Some
of the cardiomyopathy-linked mutations thus clearly affect
catalysis, while others may have subtler structural effects or
affect protein–protein interactions as proposed for the mu-
tations associated with prostate cancer susceptibility.
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